| Stock Price Performance - 12 Largest Positive Opening Gaps | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day of Event |
After Event Date (Not Including Day of Selected Event) |
||||||||||||||||
| Date | Note | Day-Of Move | Opening Gap | % Open-to-High | % Open-to-Low | Drift Open-to-Close | 1 Day | 2 Days | 3 Days | 1 Week | 2 Weeks | ||||||
| 2-Jun-2025 |
Press Releases Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference (30-May-2025, 7:00 AM Globe Newswire) Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer (2-Jun-2025, 7:00 AM Globe Newswire) HeadlineInstil Bio appoints Jamie Freedman as Chief Medical Officer (2-Jun-2025, 12:00 AM Seeking Alpha News) |
+10.0% | |||||||||||||||
| 29-May-2025 | +13.5% | ||||||||||||||||
| 22-May-2025 |
Press Release Instil Bio and ImmuneOnco Announced the Phase 2 Trial in First-line NSCLC of IMM2510/AXN-2510 ('2510), a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in China is on Track to Complete Enrollment in Q3 2025; Initial Results Anticipated in 2H 2025 (22-May-2025, 6:00 AM Globe Newswire) HeadlinesInstil Bio shares rise on immunotherapy trial updates (22-May-2025, 12:00 AM Seeking Alpha News) Instil Bio shares rise after updates on cancer trials (22-May-2025, 12:00 AM Seeking Alpha News) |
+51.7% | |||||||||||||||
| 20-May-2025 | -2.7% | ||||||||||||||||
| 23-Apr-2025 | Market Gap UpSPY had a large positive gap on the day of +2.5% | +24.4% | |||||||||||||||
| 3-Mar-2025 | Day Before EarningsTIL released earnings 4-Mar-2025 BMO | -9.1% | |||||||||||||||
| 7-Jan-2025 | +14.8% | ||||||||||||||||
| 29-Oct-2024 | -2.5% | ||||||||||||||||
| 13-Sep-2024 | +81.9% | ||||||||||||||||
| 9-Sep-2024 | +54.3% | ||||||||||||||||
| 12-Jul-2024 | +31.1% | ||||||||||||||||
| 15-Nov-2023 | Day After EarningsTIL released earnings 13-Nov-2023 AMC | -0.7% | |||||||||||||||
| Simple Average Returns - 12 Largest Positive Opening Gaps | |||||||||||||||||
| Avg Return | |||||||||||||||||
| Positive Occurrences | |||||||||||||||||
| Negative Occurrences | |||||||||||||||||
| Absolute Average Returns - 12 Largest Positive Opening Gaps | |||||||||||||||||
| Abs Avg Return | |||||||||||||||||
| Max Abs Return | |||||||||||||||||
| Min Abs Return | |||||||||||||||||
| Median, Minimum, and Maximum Returns - 12 Largest Positive Opening Gaps | |||||||||||||||||
| Median Return | |||||||||||||||||
| Max Positive Return | |||||||||||||||||
| Max Negative Return | |||||||||||||||||